NK1.1+ cells and IL-22 regulate vaccine-induced protective immunity against challenge with Mycobacterium tuberculosis

Journal of Immunology

Volumn 189, Issue 2, 2012, Pages 897-905

  Dhiman, Rohan ^a,c   Periasamy, Sivakumar ^a   Barnes, Peter F ^a,b   Jaiswal, Ankita Garg ^a   Paidipally, Padmaja ^a   Barnes, Amanda B ^a   Tvinnereim, Amy ^a   Vankayalapati, Ramakrishna ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b Health Science Center   (United States)

^c Translational Health Science and Technology Institute   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; INTERLEUKIN 22;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL IMMUNITY; BACTERIAL VIRULENCE; BCG VACCINATION; CD4+ CD25+ FOXP3+ T REGULATORY CELL; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL LYSATE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNE RESPONSE; IN VIVO STUDY; LYMPHOCYTE COUNT; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; REGULATORY T LYMPHOCYTE; T CELL DEPLETION;

ANIMALS; CELLS, CULTURED; FEMALE; INTERFERON-GAMMA; INTERLEUKINS; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; MICE; MYCOBACTERIUM BOVIS; TUBERCULOSIS VACCINES; TUBERCULOSIS, PULMONARY;

EID: 84863628133     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102833     Document Type: Article

References (45)

1. Harshan, K. V., and P. R. Gangadharam. 1991. In vivo depletion of natural killer cell activity leads to enhanced multiplication of Mycobacterium avium complex in mice. Infect. Immun. 59: 2818-2821.
2. Junqueira-Kipnis, A. P., A. Kipnis, A. Jamieson, M. G. Juarrero, A. Diefenbach, D. H. Raulet, J. Turner, and I. M. Orme. 2003. NK cells respond to pulmonary infection with Mycobacterium tuberculosis, but play a minimal role in protection. J. Immunol. 171: 6039-6045. (Pubitemid 37467223)
3. Feng, C. G., M. Kaviratne, A. G. Rothfuchs, A. Cheever, S. Hieny, H. A. Young, T. A. Wynn, and A. Sher. 2006. NK cell-derived IFN-gamma differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis. J. Immunol. 177: 7086-7093. (Pubitemid 44715076)
4. Vankayalapati, R., B. Wizel, S. E. Weis, H. Safi, D. L. Lakey, O. Mandelboim, B. Samten, A. Porgador, and P. F. Barnes. 2002. The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium. J. Immunol. 168: 3451-3457. (Pubitemid 34250410)
5. Vankayalapati, R., A. Garg, A. Porgador, D. E. Griffith, P. Klucar, H. Safi, W. M. Girard, D. Cosman, T. Spies, and P. F. Barnes. 2005. Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. J. Immunol. 175: 4611-4617. (Pubitemid 41362000)
6. Vankayalapati, R., P. Klucar, B. Wizel, S. E. Weis, B. Samten, H. Safi, H. Shams, and P. F. Barnes. 2004. NK cells regulate CD8+ T cell effector function in response to an intracellular pathogen. J. Immunol. 172: 130-137. (Pubitemid 38020464)
7. Dhiman, R., M. Indramohan, P. F. Barnes, R. C. Nayak, P. Paidipally, L. V. Rao, and R. Vankayalapati. 2009. IL-22 produced by human NK cells inhibits growth of Mycobacterium tuberculosis by enhancing phagolysosomal fusion. J. Immunol. 183: 6639-6645.
8. Roy, S., P. F. Barnes, A. Garg, S. Wu, D. Cosman, and R. Vankayalapati. 2008. NK cells lyse T regulatory cells that expand in response to an intracellular pathogen. J. Immunol. 180: 1729-1736.
9. Schierloh, P., N. Yokobori, M. Alemán, R. M. Musella, M. Beigier-Bompadre, M. A. Saab, L. Alves, E. Abbate, S. S. de la Barrera, and M. C. Sasiain. 2005. Increased susceptibility to apoptosis of CD56dimCD16+ NK cells induces the enrichment of IFN-gamma-producing CD56bright cells in tuberculous pleurisy. J. Immunol. 175: 6852-6860. (Pubitemid 41598930)
10. Bluman, E. M., G. S. Schnier, B. R. Avalos, M. P. Strout, H. Sultan, F. W. Jacobson, D. E. Williams, W. E. Carson, and M. A. Caligiuri. 1996. The c-kit ligand potentiates the allogeneic mixed lymphocyte reaction. Blood 88: 3887-3893. (Pubitemid 26383112)
11. Matos, M. E., G. S. Schnier, M. S. Beecher, L. K. Ashman, D. E. William, and M. A. Caligiuri. 1993. Expression of a functional c-kit receptor on a subset of natural killer cells. J. Exp. Med. 178: 1079-1084. (Pubitemid 23260446)
12. Hall, L. J., S. Clare, and G. Dougan. 2010. NK cells influence both innate and adaptive immune responses after mucosal immunization with antigen and mucosal adjuvant. J. Immunol. 184: 4327-4337.
13. Shafiani, S., G. Tucker-Heard, A. Kariyone, K. Takatsu, and K. B. Urdahl. 2010. Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis. J. Exp. Med. 207: 1409-1420.
14. Bayry, J., E. Z. Tchilian, M. N. Davies, E. K. Forbes, S. J. Draper, S. V. Kaveri, A. V. Hill, M. D. Kazatchkine, P. C. Beverley, D. R. Flower, and D. F. Tough. 2008. In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination. Proc. Natl. Acad. Sci. USA 105: 10221-10226.
15. Suvas, S., U. Kumaraguru, C. D. Pack, S. Lee, and B. T. Rouse. 2003. CD4+ CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses. J. Exp. Med. 198: 889-901. (Pubitemid 37152926)
16. Toka, F. N., S. Suvas, and B. T. Rouse. 2004. CD4+ CD25+ T cells regulate vaccine-generated primary and memory CD8+ T-cell responses against herpes simplex virus type 1. J. Virol. 78: 13082-13089. (Pubitemid 39507816)
17. Moore, A. C., A. Gallimore, S. J. Draper, K. R. Watkins, S. C. Gilbert, and A. V. Hill. 2005. Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance. J. Immunol. 175: 7264-7273. (Pubitemid 41713421)
18. Quinn, K. M., F. J. Rich, L. M. Goldsack, G. W. de Lisle, B. M. Buddle, B. Delahunt, and J. R. Kirman. 2008. Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis. Eur. J. Immunol. 38: 695-705.
19. Vukmanovic-Stejic, M., Y. Zhang, J. E. Cook, J. M. Fletcher, A. McQuaid, J. E. Masters, M. H. Rustin, L. S. Taams, P. C. Beverley, D. C. Macallan, and A. N. Akbar. 2006. Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. J. Clin. Invest. 116: 2423-2433. (Pubitemid 44330141)
20. Vukmanovic-Stejic, M., E. Agius, N. Booth, P. J. Dunne, K. E. Lacy, J. R. Reed, T. O. Sobande, S. Kissane, M. Salmon, M. H. Rustin, and A. N. Akbar. 2008. The kinetics of CD4+Foxp3+ T cell accumulation during a human cutaneous antigen-specific memory response in vivo. J. Clin. Invest. 118: 3639-3650.
21. Bauer, S., V. Groh, J. Wu, A. Steinle, J. H. Phillips, L. L. Lanier, and T. Spies. 1999. Activation of NK cells and T cells by NKG2D, a receptor for stressinducible MICA. Science 285: 727-729.
22. Cosman, D., J. Müllberg, C. L. Sutherland, W. Chin, R. Armitage, W. Fanslow, M. Kubin, and N. J. Chalupny. 2001. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14: 123-133. (Pubitemid 32206515)
23. Chackerian, A., J. Alt, V. Perera, and S. M. Behar. 2002. Activation of NKT cells protects mice from tuberculosis. Infect. Immun. 70: 6302-6309. (Pubitemid 35192722)
24. Sada-Ovalle, I., M. Sköld, T. Tian, G. S. Besra, and S. M. Behar. 2010. Alpha-galactosylceramide as a therapeutic agent for pulmonary Mycobacterium tuberculosis infection. Am. J. Respir. Crit. Care Med. 182: 841-847.
25. Venkataswamy, M. M., A. Baena, M. F. Goldberg, G. Bricard, J. S. Im, J. Chan, F. Reddington, G. S. Besra, W. R. Jacobs, Jr., and S. A. Porcelli. 2009. Incorporation of NKT cell-activating glycolipids enhances immunogenicity and vaccine efficacy of Mycobacterium bovis bacillus Calmette-Guerin. J. Immunol. 183: 1644-1656.
26. Xie, M. H., S. Aggarwal, W. H. Ho, J. Foster, Z. Zhang, J. Stinson, W. I. Wood, A. D. Goddard, and A. L. Gurney. 2000. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J. Biol. Chem. 275: 31335-31339.
27. Ouyang, W., J. K. Kolls, and Y. Zheng. 2008. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28: 454-467. (Pubitemid 351471762)
28. Zheng, Y., P. A. Valdez, D. M. Danilenko, Y. Hu, S. M. Sa, Q. Gong, A. R. Abbas, Z. Modrusan, N. Ghilardi, F. J. de Sauvage, and W. Ouyang. 2008. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14: 282-289. (Pubitemid 351347912)
29. Luci, C., A. Reynders, I. I. Ivanov, C. Cognet, L. Chiche, L. Chasson, J. Hardwigsen, E. Anguiano, J. Banchereau, D. Chaussabel, et al. 2009. Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat. Immunol. 10: 75-82.
30. Sanos, S. L., V. L. Bui, A. Mortha, K. Oberle, C. Heners, C. Johner, and A. Diefenbach. 2009. RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat. Immunol. 10: 83-91.
31. Cella, M., A. Fuchs, W. Vermi, F. Facchetti, K. Otero, J. K. Lennerz, J. M. Doherty, J. C. Mills, and M. Colonna. 2009. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457: 722-725.
32. Cupedo, T., N. K. Crellin, N. Papazian, E. J. Rombouts, K. Weijer, J. L. Grogan, W. E. Fibbe, J. J. Cornelissen, and H. Spits. 2009. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat. Immunol. 10: 66-74.
33. Hughes, T., B. Becknell, S. McClory, E. Briercheck, A. G. Freud, X. Zhang, H. Mao, G. Nuovo, J. Yu, and M. A. Caligiuri. 2009. Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22. Blood 113: 4008-4010.
34. Watarai, H., E. Sekine-Kondo, T. Shigeura, Y. Motomura, T. Yasuda, R. Satoh, H. Yoshida, M. Kubo, H. Kawamoto, H. Koseki, and M. Taniguchi. 2012. Development and function of invariant natural killer T cells producing T(h)2- and T (h)17-cytokines. PLoS Biol. 10: e1001255.
35. Paget, C., S. Ivanov, J. Fontaine, J. Renneson, F. Blanc, M. Pichavant, L. Dumoutier, B. Ryffel, J. C. Renauld, P. Gosset, et al. 2012. Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages. J. Biol. Chem. 287: 8816-8829.
36. Scriba, T. J., B. Kalsdorf, D. A. Abrahams, F. Isaacs, J. Hofmeister, G. Black, H. Y. Hassan, R. J. Wilkinson, G. Walzl, S. J. Gelderbloem, et al. 2008. Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response. J. Immunol. 180: 1962-1970.
37. Matthews, K., K. A. Wilkinson, B. Kalsdorf, T. Roberts, A. Diacon, G. Walzl, J. Wolske, M. Ntsekhe, F. Syed, J. Russell, et al. 2011. Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis. Tuberculosis (Edinb) 91: 587-593.
38. Zeng, G., C. Y. Chen, D. Huang, S. Yao, R. C. Wang, and Z. W. Chen. 2011. Membrane-bound IL-22 after de novo production in tuberculosis and anti-Mycobacterium tuberculosis effector function of IL-22+ CD4+ T cells. J. Immunol. 187: 190-199.
39. Wilson, M. S., C. G. Feng, D. L. Barber, F. Yarovinsky, A. W. Cheever, A. Sher, M. Grigg, M. Collins, L. Fouser, and T. A. Wynn. 2010. Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections. J. Immunol. 184: 4378-4390.
40. Khader, S. A., G. K. Bell, J. E. Pearl, J. J. Fountain, J. Rangel-Moreno, G. E. Cilley, F. Shen, S. M. Eaton, S. L. Gaffen, S. L. Swain, et al. 2007. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8: 369-377. (Pubitemid 46745412)
41. Aujla, S. J., and J. K. Kolls. 2009. IL-22: a critical mediator in mucosal host defense. J. Mol. Med. 87: 451-454.
42. Wolk, K., E. Witte, K. Witte, K. Warszawska, and R. Sabat. 2010. Biology of interleukin-22. Semin. Immunopathol. 32: 17-31.
43. Yamazaki, S., D. Dudziak, G. F. Heidkamp, C. Fiorese, A. J. Bonito, K. Inaba, M. C. Nussenzweig, and R. M. Steinman. 2008. CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells. J. Immunol. 181: 6923-6933.
44. Idoyaga, J., and R. M. Steinman. 2011. SnapShot: dendritic cells. Cell 146: 660, e2.
45. Kushwah, R., and J. Hu. 2011. Role of dendritic cells in the induction of regulatory T cells. Cell Biosci 1: 20.